Bod Science (ASX:BOD) Beneish M-Score: -4.80 (As of Jun. 26, 2026)

What is Bod Science Beneish M-Score?

Bod Science ASX:BOD 12 Beneish M-Score is -4.80 as of Jun. 26, 2026. GuruFocus rates ASX:BOD with a GF Score™ of 12/100 and a GF Value™ of A$0.04. The stock has 3 warning signs investors should review.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Bod Science's Beneish M-Score or its related term are showing as below:

ASX:BOD' s Beneish M-Score Range Over the Past 10 Years
Min: -28.05 Med: -4.8 Max: 3.99
Current: -4.8

During the past 9 years, the highest Beneish M-Score of Bod Science was 3.99. The lowest was -28.05. And the median was -4.80.

Bod Science Beneish M-Score Related Terms

Bod Science Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Bod Science's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bod Science Beneish M-Score Chart

Bod Science Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Beneish M-Score

Get a 7-Day Free Trial

-2.67

-4.50

-8.78

-14.04

-4.80

Bod Science Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25
Beneish M-Score	Get a 7-Day Free Trial													-8.78	0.00	-14.04	0.00	-4.80

ASX:BOD vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bod Science's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bod Science Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bod Science's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Bod Science's Beneish M-Score falls into.

Save Embed

12GF Score

Bod Science Ltd ASX:BOD

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bod Science Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Bod Science for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.4713

0.528 * 1.3003

0.404 * 0.1211

0.892 * 1.7168

0.115 * 1.0079

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.2723

4.679 * -0.717751

0.327 * 0.9019

-4.80

This Year (Jun25) TTM:

Last Year (Jun24) TTM:

Total Receivables was A$0.54 Mil.
Revenue was A$1.49 Mil.
Gross Profit was A$0.34 Mil.
Total Current Assets was A$2.59 Mil.
Total Assets was A$2.60 Mil.
Property, Plant and Equipment(Net PPE) was A$0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was A$0.02 Mil.
Selling, General, & Admin. Expense(SGA) was A$1.19 Mil.
Total Current Liabilities was A$7.69 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.00 Mil.
Net Income was A$0.26 Mil.
Gross Profit was A$1.19 Mil.
Cash Flow from Operations was A$0.94 Mil.

Total Receivables was A$0.21 Mil.
Revenue was A$0.87 Mil.
Gross Profit was A$0.26 Mil.
Total Current Assets was A$2.28 Mil.
Total Assets was A$2.31 Mil.
Property, Plant and Equipment(Net PPE) was A$0.01 Mil.
Depreciation, Depletion and Amortization(DDA) was A$0.21 Mil.
Selling, General, & Admin. Expense(SGA) was A$2.55 Mil.
Total Current Liabilities was A$7.58 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.538 / 1.485)	/	(0.213 / 0.865)
	=	0.36229	/	0.246243
	=	1.4713

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.256 / 0.865)	/	(0.338 / 1.485)
	=	0.295954	/	0.227609
	=	1.3003

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (2.593 + 0.001) / 2.597)	/	(1 - (2.278 + 0.007) / 2.307)
	=	0.001155	/	0.009536
	=	0.1211

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	1.485	/	0.865
	=	1.7168

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.209 / (0.209 + 0.007))	/	(0.024 / (0.024 + 0.001))
	=	0.967593	/	0.96
	=	1.0079

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.193 / 1.485)	/	(2.552 / 0.865)
	=	0.803367	/	2.950289
	=	0.2723

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 7.692) / 2.597)	/	((0 + 7.576) / 2.307)
	=	2.961879	/	3.283919
	=	0.9019

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(0.259 - 1.186	-	0.937)	/	2.597
	=	-0.717751

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Bod Science has a M-score of -4.80 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -4.80 mean?

Bod Science (ASX:BOD) has a Beneish M-Score of -4.80 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bod Science and its competitors.

Is Bod Science's Beneish M-Score too high?

Bod Science's current Beneish M-Score is -4.80. Overall, Bod Science has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Bod Science's Beneish M-Score compare to ZTS?

Bod Science's Beneish M-Score of -4.80 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Drug Manufacturers company?

A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bod Science and its competitors. Bod Science's current Beneish M-Score is -4.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bod Science stock overvalued right now?

Bod Science (ASX:BOD) has a current Beneish M-Score of -4.80. The stock's GF Value™ is A$0.04, compared to a current price of A$0.02 — trading 40% below its estimated fair value. The current Beneish M-Score is -4.80. Bod Science's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Bod Science (ASX:BOD), the current Beneish M-Score is -4.80 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bod Science (ASX:BOD) Overvalued in 2026?

Based on GuruFocus' analysis, Bod Science stock appears to be undervalued. The current stock price of A$0.02 is trading 40% below its estimated GF Value™ of A$0.04.

Key valuation signals for ASX:BOD:

Beneish M-Score: -4.80
GF Value™: A$0.04 vs. price of A$0.02 (40% below fair value)
GF Score™: 12/100 with 3 warning signs

No single metric tells the full story. See the ASX:BOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bod Science Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ASX:HGV ASX:EPN ASX:ME1 ASX:MXC ASX:EXL ASX:AGH ASX:BP8 ASX:IDT ASX:PXS ASX:ECS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Address C/- Rodgers Reidy, 210 Clarence Street, Level 12, Sydney, NSW, AUS, 2000

Website https://www.bodscience.com

Bod Science Ltd is a healthcare company combining the power of nature and science to deliver cannabis-derived health and skincare products, designed to improve lives and transform the medicinal cannabis, CBD, and hemp market. The firm is focused on cannabis drug development and products. The company is focused on progressing Research and Development and a defined clinical trial pathway to commercialize and deliver premium, scientifically trusted products for the consumer and medical markets. It earned it profits and sales revenue from Australia even though have segment in UK, Europe and USA.

12GF Score

Get the complete analysis for ASX:BOD

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.02

Price

A$0.04

GF Value

View ASX:BOD Analysis

See Beneish M-Score data for all stocks →